Status:

UNKNOWN

BIfurcation Optimal Treatment Strategy With LYMus Eluting Dedicated Bifurcation Versus Convention Stent Randomized Study

Lead Sponsor:

Medica Cor Heart Hospital

Conditions:

Coronary Bifurcation Stenosis

Eligibility:

All Genders

20-90 years

Phase:

PHASE4

Brief Summary

Study aims: to compare two intervention strategies for bifurcation treatment - provisional T-stenting (PTS) with drug-eluting stent (sirolimus eluting), with kissing balloon inflation at the end of pr...

Detailed Description

The coronary bifurcation lesions pose a therapeutic problem with high rates of periprocedural complications, higher rates of in-stent restenosis and stent thrombosis. These are lesions where stenting ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Subject at least 18 years of age.
  • Subject able to verbally confirm understandings of risks, benefits of receiving PCI for true bifurcation lesions, and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
  • Target main branch lesion(s) located in a native coronary artery with diameter of ≥ 2.5 mm and ≤ 4.5 mm. Target side branch lesion(s) located in a native coronary artery with diameter of ≥ 2.0 mm.
  • Target lesion(s) amenable for PCI with balloon angioplasty of the side branch.
  • Exclusion Criteria
  • STEMI
  • Non-cardiac co-morbid conditions are present with life expectancy \<1 year or that may result in protocol non-compliance (per site investigator's medical judgment).
  • Subjects who refuse to give informed consent.
  • Subjects with LVEF\<30%
  • Subjects with moderate or severe degree valvular heart disease or primary cardiomyopathy
  • Contraindications for 12 months DAP

Exclusion

    Key Trial Info

    Start Date :

    September 1 2011

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2014

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT01430364

    Start Date

    September 1 2011

    End Date

    May 1 2014

    Last Update

    December 25 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Medica Cor Heart Hospital

    Rousse, Bulgaria, 7000